Riskpilot← Back to searchSign inGet full accessFlamholc medical AB
ABActiveOrg 5566164140Other human health activities n.e.c. · NACE 8699Est. 20010 employees
Revenue 2025
—
EBITDA margin
—
-27% vs 2024
Equity ratio
98.9%
Financial strength
Net profit 2025
SEK 85K
-6% vs 2024
| Revenue | — | — |
| EBITDA | SEK -17K | -27% |
| Net profit | SEK 85K | -6% |
| Total assets | SEK 3,3M | -3% |
| Equity | SEK 3,2M | -4% |
| Employees | 0 | — |
Legal name
Flamholc medical AB
Org number
5566164140
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
8 oktober 2001
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Flamholc, Leo
Company purpose
Bolaget skall bedriva kapitalförvaltning.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −12 | −14 | −14 | −14 | −17 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −12 | −14 | −14 | −14 | −17 |
| Net financials | 85 | 74 | 86 | 128 | 125 |
| Profit before tax | 73 | 60 | 72 | 115 | 107 |
| Tax | −16 | −12 | −15 | −24 | −22 |
| Net profit | 57 | 48 | 58 | 91 | 85 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 783 | 3 639 | 3 504 | 3 399 | 3 285 |
| Equity | 3 763 | 3 623 | 3 485 | 3 372 | 3 248 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 20 | 16 | 18 | 27 | 37 |
| Total debt | 20 | 16 | 18 | 27 | 37 |
EBITDA margin
-1746500.0%
This company
15.8%
Market median
-11053897% vs market
20212025
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
2.6%
This company
18.4%
Market median
-86% vs market
20212025
Net profit margin
8525800.0%
This company
8.1%
Market median
+105256690% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Flamholc medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leo Flamholc | Board of Directors | 0 companies |
| Kerstin Annette Cecilia Flamholc | Deputy Board Member | 0 companies |
| Piotr Flamholc | Deputy Board Member | 0 companies |